Form 4: Select Medical Holdings Executive Vice President Michael Tarvin Reports Stock Transaction

Michael Tarvin, Executive Vice President of Select Medical Holdings, reports the surrender of shares to cover tax obligations related to vesting restricted stock.

Summary

• On April 30, 2025, Michael E. Tarvin, Executive Vice President of Select Medical Holdings Corporation, reported a transaction involving common stock.
• Tarvin surrendered 9,034 shares of common stock at a price of $18.24 to satisfy tax withholding obligations related to the vesting of restricted stock.
• Following the transaction, Tarvin directly owns 427,760 shares of Select Medical Holdings Corporation.
• The transaction was reported on May 1, 2025.

Sentiment

Score: 5

Explanation: This is a neutral report of a routine transaction. It doesn't indicate positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates

Keywords

Select Medical Holdings, Michael Tarvin, Form 4, Stock Transaction, Executive Vice President, Restricted Stock, Tax Withholding, Beneficial Ownership